-
dedup_wf_001--5a8e794a989a74f2712444861a1f8eeb
Additional file 2: Supplemental flow diagram. This diagram shows the specific variables assessed at each specific timepoint. -
Chemical profiling, antioxidant, and antimicrobial activities of Indian sting...
In India, stingless bee propolis has not yet been received commercial importance due to lack of information about its chemical composition and health benefits. Therefore,... -
dedup_wf_001--09ce30d23f32057947fd1c1327a075f4
Additional file 1: Table S1. Baseline characteristics (KORA S4, 1999-2001) of participants and non-participants in KORA F4 (2006-2008). Table S2. Association between SFRP5 serum... -
Additional file 4: of Oral prednisolone for acute otitis media in children: p...
Training slidesâ Pilot OPAL Study. The training slide was presented during the training for participating physicians, audiologists, nurses, and pharmacists. The training was... -
dedup_wf_001--d73dea0d494e6e16068cdd8f28cbd3e7
Comparison of women with suspected cystitis included and excluded from the validation cohort analysis; and with the development cohort [8]. Table S2. Comparison of physician... -
dedup_wf_001--4c53005d84f9d5615d40b3fe221b8f95
Additional file 1: Table S1. International Classification of Diseases (ICD-9) system codes collected during follow-up. Table S2. Baseline clinical characteristics of individuals... -
Additional file 2: of Clinical study of children with Takayasu arteritis: a r...
Angiographic classification and percentages of 11 TA children. (DOCX 12 kb) -
dedup_wf_001--e028c56c76475f2f322639fef0d7b614
Patient characteristics by PAH status. Table S2. Baseline haemodynamics of SSc-PAH patients according to PAH therapy and anticoagulation. Table S3. Predictors of mortality in... -
Additional file 5 of German recommendations for physical activity and physica...
Additional file 5. Quality criteria for the conceptualization, implementation and evaluation of PA promoting interventions. This table lists the general quality criteria for PA... -
Additional file 2: of Herd-level seroprevalence of Fasciola hepatica and Oste...
Detailed data regarding cattle herds enrolled in the study. Detailed data regarding cattle herds enrolled in the study including province, optical density ratio (ODR) in... -
Additional file 1: Table S1. of Single- and multiple viral respiratory infect...
Modified disease severity score after Gern [17, 18]. (DOCX 14 kb) -
Importance of comorbidities in comatose survivors of shockable and non-shocka...
Objective. Comorbidity prior to out-of-hospital cardiac arrest (OHCA) and primary rhythm in relation to survival is not well established. We aimed to assess the prognostic... -
Additional file 6 of Real-world patient-reported outcomes of women receiving ...
Additional file 6: Table S6A. Factors associated with HRQoL (EORTC QLQ-C30 global health/QoL scale score) from multiple linear regression analysis for patients with HR+/HER2−... -
Additional file 4: of Associating expression and genomic data using co-occurr...
Figure S4. Survival characteristics of the patients that have a mutation in TP53 and low expression in ESR1 (TP53-ESR1, green). The survival curve is compared against a group... -
Additional file 3: of A phase III randomized study to evaluate the efficacy a...
Improvement in patient-reported outcomes with CT-P13 and RP in the intent-to-treat population. (DOC 52 kb) -
dedup_wf_001--18d20154758199fd3807c768a6b8a14e
APAIS and VAS scores. This supplement shows a table presenting mean anxiety levels (APAIS and VAS scores) of all patients (n = 3087) and the subset of patients with high anxiety... -
dedup_wf_001--92a5f95aafb8c655cecccbba1e68999b
Additional file 7: Table S5. Time to first severe SFI flare over 52 weeks. -
Additional file 6 of Development and psychometric evaluation of the assessmen...
Additional file 6: Table S6. Fit summary of CFA on the pre- and post-injection ASI modules. AGFI adjusted goodness-of-fit index, ASI Assessment of Self-Injection, CFA... -
Additional file 1: of Supplemental parenteral nutrition in critically ill pat...
Detailed product information for the interventional product. (DOCX 14Â kb)
